Name of opportunity: 👀
Moderna, Inc.
Rising again ↗️
Moderna is a growth stock that doesn’t pay dividends, but reinvests profits to grow the business. Currently, Moderna has a strong gross margin and solid cash flow, which indicates that the company is performing well financially.
Moderna’s stock price has dropped over the past year however, despite currently being on the rise.
Despite an underwhelming year for the stock, analysts are predicting Moderna might keep rising in price over the next 12 months.
How hot is this investment opportunity? 🔥🔥
Analysts predict the price of Moderna, Inc. might increase from $47.53 to $111.62 in the next 12 months. If you invested $1000, you might profit $1348.39.
One reason for the recent price increase might be because Moderna is currently developing a H5N1 vaccine for bird flu. Unfortunately the U.S has reported a bird flu death recently. As Moderna is currently working on a vaccine for this, it might be why the stock price has increased.
Another reason why Moderna has seen an increase might be because there has been a spike in Covid-19 cases over the past two weeks in the U.S, according to the Centers for Disease Control and Prevention (CDC). Moderna sells a Covid vaccine - which is why the stock price might have increased recently.
However, analysts are still recommending to ‘hold’ shares for the time being - so this might be a stock to watch in the weeks and months to come.
Biotech company 💉
Moderna, Inc. is an American biotechnology and pharmaceuticals company that develops mRNA vaccines. The company is headquartered in Cambridge, Massachusetts, United States.
Which neme?: 🔍
‘Pharma’, ‘Top Biotech Stocks’, ‘Top Gainers Today’, ‘Stocks On The Move’.
Download Nemo Money to check out Moderna, Inc. New users can grab our registration bonus up to a maximum of $50. Top up your account and get 50% extra from us. Terms and conditions apply.
